
    
      Women with twin pregnancy with transvaginal sonographic cervical length of 20-25 mm at 20-24
      weeks gestational age without symptoms, signs or other risk factors of preterm labor will be
      included in the study. All women will be randomly divided into two groups; one group (study
      group) received vaginal progesterone suppositories in a dose of 400 mg daily beginning at
      20-24 weeks gestational age (study group) and the other group received no treatment (control
      group)
    
  